The Dynasty Wire
September 11, 2026

Dynasty Market Report — September 11, 2026

The Lede

The dynasty market is pricing in career-altering Week 1 injury news with brutal efficiency today, as three young quarterbacks crater simultaneously — Shedeur Sanders, J.J. McCarthy, and Cyrus Allen's supporting cast all hemorrhaging value in a single session. The scale of these moves (-55% to -65%) signals confirmed, significant injuries rather than speculation. This is a restructuring event for multiple rosters, not a one-day blip.

Who's Rising

Late-round picks are quietly becoming the story underneath the carnage: the 2026 4th surged +39.36% to DME 1,657, almost certainly absorbing demand from managers scrambling to restock after roster hits. The 2026 Early 1st climbed to DME 5,669 (+9.76%), reflecting both real optimism about the upcoming class and a flight to draft capital as a safe-harbor asset. Bijan Robinson's +5.68% move to DME 10,265 is the cleanest buy-hold signal of the week — a bell-cow RB in his prime getting healthier market respect; hold firm and ask for a premium if selling.

Who's Falling

Shedeur Sanders crashing to DME 1,013 (-64.79%) is the headline, and the McCarthy collapse to DME 1,113 (-55.64%) confirms these are injury-driven, not performance-driven declines — which matters enormously for buy-low targeting. The supporting-cast wipeout in Tampa — Kenneth Gainwell (DME 1,310) and Jalen McMillan (DME 1,092) dropping in tandem — points to a TB offensive situation turning ugly fast; treat those as sell-into-weakness names, not rebounds. Zachariah Branch falling to DME 1,080 in Atlanta is the lone potential buy-low given Bijan's rising tide.

The Move

Target J.J. McCarthy at DME 1,113. A -55.64% single-week drop on an unproven young QB in a Superflex format almost always overshoots reality — managers are panic-selling, not analyzing. His age, draft pedigree, and Minnesota's infrastructure remain intact. Offer a mid-2027 pick and a depth receiver to a rattled McCarthy manager today, before the injury timeline clarifies and the price floor firms back up.